Amy Schacterle
Directeur des opérations chez SAGE THERAPEUTICS, INC.
Postes actifs de Amy Schacterle
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SAGE THERAPEUTICS, INC. | Directeur des opérations | 01/04/2020 | - |
| Directeur Technique/Scientifique/R&D | 01/04/2020 | - | |
| Conseiller Juridique Général | 13/02/2015 | 01/04/2020 |
Historique de carrière de Amy Schacterle
Anciens postes connus de Amy Schacterle
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Conseiller Juridique Général | 01/01/2004 | 01/01/2014 |
Formation de Amy Schacterle
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| General Counsel | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Bourse
- Insiders
- Amy Schacterle
- Expérience
